Delcath Systems - Bathi operasional EBITDA DCTH
Delcath Systems, Inc. (DCTH) is focusing on the independent market launch of its liver therapy system. The cash EBITDA figure confirms this stage, recording the metric at 0.00. However, geopolitical tensions and export restrictions could hinder global growth. Additional challenges include innovative treatment methods from industry behemoths, creating fierce competition within the high-tech oncology sector.
Delcath Systems (DCTH) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Utang marang Ekuitas Delcath Systems, Inc.|DCTH - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Delcath Systems Inc|DCTH - Utang perusahaan|Rasio utang marang kapitalisasi buku Delcath Systems|DCTH - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Delcath Systems|Rasio cepet delcath.com
- statistik bathi lan rasio pasar:
DCTH - Penghasilan resik|Bathi resik mangsa ngarep Delcath Systems, Inc.|DCTH - Pangali P/E|Pangali mangsa ngarep rega marang bathi delcath.com|DCTH - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Delcath Systems|DCTH - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Delcath Systems|DCTH - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan delcath.com|DCTH - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Delcath Systems, Inc.
Analisis kabeh metrik perusahaan:Delcath Corp (DCTH)
This indicator measures daily cash flow from core operations before interest and taxes, allowing for an assessment of operational resilience and the business's actual ability to generate cash. For Delcath Systems, Inc. (DCTH) with its asset-light model and outsourced production, the company's aggregate EBITDA demonstrates the efficiency of commercializing R&D solutions without the burden of capital expenditures for manufacturing plants.
Karo sapa Delcath Systems, Inc. saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional EBITDA PSNL|erasca.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA YMAB (Y-mAbs Therapeutics, Inc.)|Aura Biosciences Inc (AURA) - Bathi sadurunge bunga, pajak, lan amortisasi|CADL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ARAY: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLS: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi actuatetherapeutics.com|CTOR (Citius Oncology) - Bathi operasional EBITDA|Bathi operasional EBITDA TuHURA|Bathi operasional sadurunge ngurangi amortisasi TARA (Protara)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi FATE|Bathi operasional EBITDA WHWK (Aadi Bioscience)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TCRX|CSBR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi XBIT (XBiotech Inc.)|cel-sci.com (CVM) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|OSTX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi RADX|Bathi sadurunge bunga, pajak, lan amortisasi Artiva ARTV|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Adlai Nortye Ltd. (ANL)|Pendapatan operasional sadurunge ngurangi amortisasi Veru Inc|Tempest Tx - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi XLO (Xilio Therapeutics Inc)|Enochian BioSciences - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Mural Oncology plc|kairospharma.com (KAPA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi OnKure Therapeutics|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CytoMed Therapeutics Ltd|Curis Corp (CRIS) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi APLM (Apollomics, Inc.)|THAR (tharimmune.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ADVB (Advanced Biomed)|Pendapatan operasional sadurunge ngurangi amortisasi Genprex Inc. (GNPX)|CLDI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SBFM (sunshinebiopharma.com) - Bathi operasional sadurunge amortisasi|XBIO: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi salariuspharma.com|Bathi operasional sadurunge ngurangi amortisasi PPBT|AON (AONC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA BGNE|Checkpoint Therapeutics Inc - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA ELEV (Elevation Oncology)|ICAD - Bathi operasional sadurunge ngurangi amortisasi|IKNA: Bathi operasional sadurunge ngurangi amortisasi|Notable Labs Ltd - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|VIRX: Bathi operasional EBITDA|MorphoSys Corporation - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ascentage.com (AAPGV)
